BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15847628)

  • 1. Nicotine analogues: a review of tobacco industry research interests.
    Vagg R; Chapman S
    Addiction; 2005 May; 100(5):701-12. PubMed ID: 15847628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What should be the elements of any settlement with the tobacco industry?
    Burns D; Benowitz N; N'Connolly GN; Cummings KM; Davis RM; Henningfield JE; Shopland DR; Warner KE
    Tob Control; 1997; 6(1):1-4. PubMed ID: 9176975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes.
    Dunsby J; Bero L
    Tob Control; 2004 Dec; 13(4):362-9. PubMed ID: 15564619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine psychopharmacology: policy and regulatory.
    Henningfield JE; Zeller M
    Handb Exp Pharmacol; 2009; (192):511-34. PubMed ID: 19184661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco industry manipulation of nicotine dosing.
    Wayne GF; Carpenter CM
    Handb Exp Pharmacol; 2009; (192):457-85. PubMed ID: 19184659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cigarette controversy.
    Cummings KM; Brown A; O'Connor R
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1070-6. PubMed ID: 17548665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The case for the plain packaging of tobacco products.
    Freeman B; Chapman S; Rimmer M
    Addiction; 2008 Apr; 103(4):580-90. PubMed ID: 18339104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The scientific basis of tobacco product regulation.
    WHO Study Group
    World Health Organ Tech Rep Ser; 2007; (945):1-112, back cover. PubMed ID: 17802809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco industry sponsorship of a book and conflict of interest.
    Hong MK; Bero LA
    Addiction; 2006 Aug; 101(8):1202-11. PubMed ID: 16869850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing cigarettes for women: new findings from the tobacco industry documents.
    Carpenter CM; Wayne GF; Connolly GN
    Addiction; 2005 Jun; 100(6):837-51. PubMed ID: 15918814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The scientific basis of tobacco product regulation.
    Ashley DL; Burns D; Djordjevic M; Dybing E; Gray N; Hammond SK; Henningfield J; Jarvis M; Reddy KS; Robertson C; Zaatari G;
    World Health Organ Tech Rep Ser; 2008; (951):1-277, 1 p following 277. PubMed ID: 19522165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco industry knowledge of the role of menthol in chemosensory perception of tobacco smoke.
    Kreslake JM; Yerger VB
    Nicotine Tob Res; 2010 Dec; 12 Suppl 2():S98-101. PubMed ID: 21177374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of sensory perception in the development and targeting of tobacco products.
    Carpenter CM; Wayne GF; Connolly GN
    Addiction; 2007 Jan; 102(1):136-47. PubMed ID: 17207131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research into smoking or nicotine and human cognitive performance: does the source of funding make a difference?
    Turner C; Spilich GJ
    Addiction; 1997 Nov; 92(11):1423-6. PubMed ID: 9519485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco control implications of the first European product liability suit.
    Hiilamo HT
    Tob Control; 2005 Feb; 14(1):22-30. PubMed ID: 15735296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rethinking the regulatory framework for tobacco control in New Zealand.
    Thomson G; Wilson N; Crane J
    N Z Med J; 2005 Apr; 118(1213):U1405. PubMed ID: 15843834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. After the Master Settlement Agreement: trends in the American tobacco retail environment from 1999 to 2002.
    Ruel E; Mani N; Sandoval A; Terry-McElrath Y; Slater SJ; Tworek C; Chaloupka FJ
    Health Promot Pract; 2004 Jul; 5(3 Suppl):99S-110S. PubMed ID: 15231103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco industry research and efforts to manipulate smoke particle size: implications for product regulation.
    Wayne GF; Connolly GN; Henningfield JE; Farone WA
    Nicotine Tob Res; 2008 Apr; 10(4):613-25. PubMed ID: 18418784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
    Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK
    Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing smokeless tobacco products for smokers: an examination of tobacco industry documents.
    Carpenter CM; Connolly GN; Ayo-Yusuf OA; Wayne GF
    Tob Control; 2009 Feb; 18(1):54-9. PubMed ID: 18948390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.